Clinical Trial Update: A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of KD033 (SAR445710) in Subjects With Metastatic or Locally Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of KD033 (SAR445710) in metastatic or locally advanced solid tumors has been terminated; the document provides trial details including safety, pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• KD033 (SAR445710) (SAR445710)

Snippet

Sponsor: Kadmon, a Sanofi Company | Conditions: Solid Tumor | Phase 1 | Status: TERMINATED